Precision Business Insights
Portfolio

 

Research Reports

Poultry Vaccines Market by Vaccine type, Formulation, Application: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis and Forecast 2017 to 2024

Poultry Vaccines Market by Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Others), and Geography.

 

Poultry Vaccines Market Dynamics

 

Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat, rise in number of poultry industries, grow in R&D for the innovation of newer vaccines, and rise in prevalence of various infectious diseases are anticipated to fuel poultry vaccines market over the forecast period.

 

Furthermore, government initiations for protecting the animal health, rise in veterinary healthcare expenditure, and vaccination programs organized by the companies are expected to boost the market over the forecast period. However, stringent regulatory guidelines for the vaccine approval, adverse effects associated with vaccines, high R&D expenditure, and increase in adoption of vegetarian food may restrain the growth of market over the forecast timeframe.

 

Poultry Vaccines Market Segmentation

The market is segmented on the basis of vaccine type, formulation, application, and region

 

Based on the vaccine type, the market is segmented into the following:

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines

 

Based on the formulation, the market is segmented into the following:

  • Dry Form (Duct) Vaccines
  • Liquid Vaccines
  • Freeze Dried Vaccines

 

Based on the application, the market is segmented into the following:

  • Marek’s Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Others

 

Based on the region, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Poultry Vaccines Market Regional Analysis

 

Geographically, global poultry vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America poultry vaccines market has a significant share owing to rise in demand for healthy meat, increase in R&D for the innovation of newer vaccines, and rise in veterinary healthcare expenditure. Europe poultry vaccines market is growing due to launching of newer vaccines into market, rise in prevalence of poultry diseases, and grow in per capita income.

 

Asia Pacific poultry vaccines market is expected to exhibit significant growth rate over the forecast period owing to increase in poultry production, government vaccination programs, and rise in population demand for healthy meat in China and India. Latin America poultry vaccines market growing due to adoption of newer vaccines, economic growth, and increase in consumption of poultry meat are propel the market. Middle East and Africa poultry vaccines market is driven by expansion of business by companies, rise in prevalence of zoonotic diseases, and increase in awareness about the vaccines expected to upsurge the revenue of market.

 

Competition Assessment

  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Indovax Pvt. Ltd. (India)
  • Hester Biosciences Limited. (India)
  • Zydus AHL (India)

 

Notable Market Developments

  • In November 2017, French firm Ceva Sante Animale launched two new poultry vaccines in India through joint venture with Ceva Polchem for the treatment of Gumboro disease and Ranikhet disease.

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

1. Executive Summary

2. Global Poultry Vaccines Market Introduction

 2.1. Global Poultry Vaccines Market – Taxonomy
 2.2. Global Poultry Vaccines Market –Definitions
 2.2.1. Vaccine Type

 2.2.2. Application

3. Global Poultry Vaccines Market Dynamics

 3.1. Drivers
 3.2. Restraints
 3.3. Opportunities/Unmet Needs of the Market
 3.4. Trends
 3.5. Global Poultry Vaccines Market Dynamic Factors – Impact Analysis
 3.6. Global Poultry Vaccines Market – Regulations
 3.6.1. U.S.

 3.6.2. Europe

4. Global Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

 4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

 4.3. Market Opportunity Analysis

5. Global Poultry Vaccines Market Analysis, By Vaccine Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 5.1. Inactivated Vaccines
 5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 5.1.3. Market Opportunity Analysis
 5.2. Live Attenuated Vaccines
 5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 5.2.3. Market Opportunity Analysis
 5.3. Recombinant Vaccines
 5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

 5.3.3. Market Opportunity Analysis

6. Global Poultry Vaccines Market Analysis, By Application, 2013 – 2017 and Forecast, 2018 – 2024

 6.1. Marek’s Disease
 6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 6.1.3. Market Opportunity Analysis
 6.2. Newcastle Disease
 6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 6.2.3. Market Opportunity Analysis
 6.3. Infectious Bursal Disease
 6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 6.3.3. Market Opportunity Analysis
 6.4. Infectious Bronchitis
 6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 6.4.3. Market Opportunity Analysis
 6.5. Others
 6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

 6.5.3. Market Opportunity Analysis

7. Global Poultry Vaccines Market Analysis, By Formulation, 2013 – 2017 and Forecast, 2018 – 2024

 7.1. Dry Form (Duct) Vaccines
 7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 7.1.3. Market Opportunity Analysis
 7.2. Liquid Vaccines
 7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 7.2.3. Market Opportunity Analysis
 7.3. Freeze Dried Vaccines
 7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

 7.3.3. Market Opportunity Analysis

8. Global Poultry Vaccines Market Analysis, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 8.1. North America
 8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 8.1.3. Market Opportunity Analysis
 8.2. Europe
 8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 8.2.3. Market Opportunity Analysis
 8.3. Asia-Pacific
 8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 8.3.3. Market Opportunity Analysis
 8.4. Latin America
 8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 8.4.3. Market Opportunity Analysis
 8.5. Middle East and Africa
 8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
 8.5.3. Market Opportunity Analysis

 8.6. Global Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2018 – 2024

9. North America Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 9.1. Vaccine Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
 9.1.1. Inactivated Vaccines
 9.1.2. Live Attenuated Vaccines
 9.1.3. Recombinant Vaccines
 9.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
 9.2.1. Marek’s Disease
 9.2.2. Newcastle Disease
 9.2.3. Infectious Bursal Disease
 9.2.4. Infectious Bronchitis
 9.2.5. Others
 9.3. Formulation Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
 9.3.1. Dry Form (Duct) Vaccines
 9.3.2. Liquid Vaccines
 9.3.3. Freeze Dried Vaccines
 9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
 9.4.1. U.S.
 9.4.2. Canada
 9.5. North America Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024

 9.6. North America Poultry Vaccines Market Dynamics – Trends

10. Europe Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 10.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
 10.1.1. Germany
 10.1.2. UK
 10.1.3. France
 10.1.4. Spain
 10.1.5. Italy
 10.1.6. Russia
 10.1.7. Poland
 10.1.8. Rest of Europe
 10.2. Europe Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024

 10.3. Europe Poultry Vaccines Market Dynamics – Trends

11. Asia-Pacific Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 11.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
 11.1.1. Japan
 11.1.2. China
 11.1.3. India
 11.1.4. ASEAN
 11.1.5. Australia & New Zealand
 11.1.6. Rest of Asia-Pacific
 11.2. Asia-Pacific Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024

 11.3. Asia-Pacific Poultry Vaccines Market Dynamics – Trends

12. Latin America Poultry Vaccines Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 12.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
 12.1.1. Brazil
 12.1.2. Mexico
 12.1.3. Argentina
 12.1.4. Venezuela
 12.1.5. Rest of Latin America
 12.2. Latin America Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024

 12.3. Latin America Poultry Vaccines Market Dynamics – Trends

13. Middle East and Africa Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 13.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
 13.1.1. Gulf Cooperation Council (GCC) Countries
 13.1.2. Israel
 13.1.3. South Africa
 13.1.4. Rest of MEA
 13.2. MEA Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024

 13.3. MEA Poultry Vaccines Market Dynamics – Trends

14. Competition Landscape

 14.1. Strategic Dashboard of Top Market Players
 14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
 14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
 14.2.2. Merck & Co. Inc. (U.S)
 14.2.3. Boehringer Ingelheim Vetmedica (Germany)
 14.2.4. Elanco (U.S.)
 14.2.5. Bayer Animal Health (Germany)
 14.2.6. Ceva Sante Animale (France)
 14.2.7. Indovax Pvt. Ltd. (India)
 14.2.8. Hester Biosciences Limited. (India)

 14.2.9. Zydus AHL (India)

15. Research Methodology

16. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

Ask An Analyst